$ADMA ADMA BIOLOGICS, INC. Insider Trading
FREE EMAIL WATCHDOG
Get free email notifications about insider trading in ADMA BIOLOGICS, INC..
- Your email is safe with us.
- The service is free and you can unsubscribe at any time.
General | Insiders | Insider Transactions | Monthly Overview | Weekly Overview
Overview of insider trading in ADMA BIOLOGICS, INC.. Insider overview, share value development, latest insider transactions and email notifications about new events in ADMA BIOLOGICS, INC. for free.
IRS Number: 562590442
Industry: BIOLOGICAL PRODUCTS (NO DIAGNOSTIC SUBSTANCES) [2836]
Trading Symbol: ADMA
Company Address: C/O ADMA BIOLOGICS, INC. 465 STATE ROUTE 17 RAMSEY 07446
Phone number: (201) 478-5552
Former name: R&R ACQUISITION VI, INC, date of change: 2006-07-07
Market Capitalization: $63.82M
Prev close: $5.00
Average Daily Volume: 31,140
Days Low: $4.92
Year Low: $4.15
Year High: $8.85
ADMA BIOLOGICS, INC. Latest Insider Transactions
| Date | Ticker | Company | Owner | Relationship | Transaction | Code | Cost ($) | Shares | Transaction Value ($) | Total Shares | % Holdings |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Guiheen Lawrence P. | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Fong Bryant | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | ELMS STEVE | Director | Option Exercise | A | 2.35 | 55,000 | 129,250 | 55,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Option Exercise | A | 2.35 | 458,700 | 1,077,945 | 458,700 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Grant | A | 0.00 | 221,447 | 0 | 397,545 | 176.1 K to 397.5 K (+125.75 %) |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Option Exercise | A | 2.35 | 139,000 | 326,650 | 139,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Grant | A | 0.00 | 64,361 | 0 | 137,535 | 73.2 K to 137.5 K (+87.96 %) |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Option Exercise | A | 2.35 | 139,000 | 326,650 | 139,000 | |
| Mar 01 2021 | ADMA | ADMA BIOLOGICS, IN ... | LENZ BRIAN | EVP, CFO | Grant | A | 0.00 | 63,936 | 0 | 140,078 | 76.1 K to 140.1 K (+83.97 %) |
| Sep 14 2020 | ADMA | ADMA BIOLOGICS, IN ... | DEMSKI MARTHA J | Director | Buy | P | 2.29 | 2,200 | 5,038 | 4,200 | 2 K to 4.2 K (+110.00 %) |
| Sep 11 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Jerrold B | Director | Buy | P | 2.22 | 5,000 | 11,100 | 160,864 | 155.9 K to 160.9 K (+3.21 %) |
| Sep 10 2020 | ADMA | ADMA BIOLOGICS, IN ... | Mond James | EVP, CSO and CMO | Buy | P | 2.20 | 4,000 | 8,800 | 73,174 | 69.2 K to 73.2 K (+5.78 %) |
| Sep 10 2020 | ADMA | ADMA BIOLOGICS, IN ... | Grossman Adam S | President and CEO | Buy | P | 2.24 | 4,000 | 8,960 | 176,098 | 172.1 K to 176.1 K (+2.32 %) |